Choline Bitartrate Market size is set to reach USD 620 million by 2028, according to a new research report by Global Market Insights Inc.
Choline bitartrate has high nutritive value and helps in overall health enhancement, this factor is helping it to penetrate in dietary supplements industry. Rising awareness and acceptance of choline bitartrate as active pharmaceutical ingredients will boost the industry growth.
Increasing inclusion of L-type choline bitartrate in dietary supplements is anticipated to propel the market expansion.
Choline bitartrate market from L-type segment surpassed USD 185 million in 2021 and is expected to witness 6% CAGR through 2028. L-type choline bitartrate is produced by the combination of choline and L-tartaric acid. L-tartaric acid occurs naturally and mostly derived from grape juice. L-type is used in production of capsules, tablets, and powders.
L-type is a lipotropic compound widely used in pharmaceuticals and nutraceuticals industry due to its health benefits such as maintaining cellular structure, increasing absorption rate, boosting power, and supplying nutrients to vital organs. Its powder is available in pure form for direct consumption and is often added to green drinks, smoothies, food, and beverages.
L-type is also added in manufacturing of multivitamins tablets and capsules. In addition to choline bitartrate, tablets also contain other essential micronutrients. Owing to pandemic, there was rise in consumption of multi vitamins which boosted the industry landscape. Increasing health consciousness, rise in fitness centers and gym and growth of e-commerce are slated to propel market progression.
Browse key industry insights spread across 200 pages with 154 market data tables and 21 figures & charts from the report, “Choline Bitartrate Market Analysis By Type (L-Type, D-Type, DL-Type), Application (Pharmaceutical & Nutritional Supplement, Baby Food, Food & Beverage,) Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents:
Growing demand of nutraceuticals for parental mother and children is likely to drive market demand.
Choline bitartrate market from pharmaceutical & nutritional supplement segment is set to exceed USD 270 million by 2028 and projected to register 6% CAGR during the forecast period. The choline bitartrate is used in manufacturing of supplements such as gummies, capsules, and powders. Due to the lack of balanced diet the demand for nutraceutical supplements is on rise which is predicted to augment the market forecasts.
Insufficient level of choline in mother can cause defects of neural tube and spinal cord in fetus. To avoid this choline bitartrate supplements are often recommended to parental mother and children. As children consume gummies easily than tablets and powders the demand for choline bitrate gummy supplements is estimated to rise in near future. Growing concerns of parents, along with an increase in the birth rate, are projected to fuel the business expansion.
Growing demand for sports nutrition among professionals and general young population is anticipated to stimulate the market share in Europe.
Europe choline bitartrate market is likely to cross USD 145 million by 2028 growing at a CAGR of over 5.5% owing to its increasing consumption as a sports nutrition. Choline is used as energy booster thus increasing popularity of energy drinks is predicted to foster the regional market expansion.
Increasing popularity of supplements among middle-aged people coupled with rising availability of various products in pharmacies and convenience stores is poised to accelerate the product demand. Increasing per capita income of European population, has also raised the demand for premium health products.
Major players in global choline bitartrate industry are Arochem Industries, Glentham Life Sciences Limited, Salvi Chemical Industries Ltd, NutriScience Innovations LLC, Balchem Inc, Cepham Life Sciences, TCI Chemicals (India) Pvt. Ltd, Finetech Industry Limited, Alfa Aesar, and Jinan Pengbo Biotechnology Co., Ltd.